UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

Clinical infectious diseases, 2004-11, Vol.39 (10), p.1407-1416

2004

Volltextzugriff (PDF)

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Leukemia, 2010-06, Vol.24 (6), p.1121-1127

2010

Volltextzugriff (PDF)

Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study

Leukemia, 2012-12, Vol.26 (12), p.2517-2520

2012

Volltextzugriff (PDF)

Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

Leukemia, 2017-12, Vol.31 (12), p.2695-2701

2017

Volltextzugriff (PDF)

Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.416-421

2014

Volltextzugriff (PDF)

Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial

Leukemia, 2010-08, Vol.24 (8), p.1406-1411

2010

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for multiple myeloma: is there a future?

Bone marrow transplantation (Basingstoke), 2016-04, Vol.51 (4), p.492-500

2016

Volltextzugriff (PDF)

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I II trial

Bone marrow transplantation (Basingstoke), 2003-07, Vol.32 (2), p.177-186

2003

Volltextzugriff (PDF)

Graft-Versus-Myeloma Effect: Proof of Principle

Blood, 1996-02, Vol.87 (3), p.1196-1198

1996

Volltextzugriff (PDF)

Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma

Blood, 1997-02, Vol.89 (3), p.789-793

1997

Volltextzugriff (PDF)

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1547-1553

1998

Volltextzugriff (PDF)

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

Leukemia, 2012-05, Vol.26 (5), p.1091-1097

2012

Volltextzugriff (PDF)

A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study

Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (2), p.149-154

2004

Volltextzugriff (PDF)

Poor Prognosis in Multiple Myeloma Is Associated Only With Partial or Complete Deletions of Chromosome 13 or Abnormalities Involving 11q and Not With Other Karyotype Abnormalities

Blood, 1995-12, Vol.86 (11), p.4250-4256

1995

Volltextzugriff (PDF)

Cure of multiple myeloma - more hype, less reality

Bone marrow transplantation (Basingstoke), 2006-01, Vol.37 (1), p.1-18

2006

Volltextzugriff (PDF)

Autotransplants in Multiple Myeloma: What Have We Learned?

Blood, 1996-08, Vol.88 (3), p.838-847

1996

Volltextzugriff (PDF)

Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF)

Bone marrow transplantation (Basingstoke), 2003-01, Vol.31 (2), p.113-116

2003

Volltextzugriff (PDF)

Successful Treatment of Systemic and Central Nervous System Lymphomatoid Granulomatosis with Rituximab

Leukemia & lymphoma, 2004-04, Vol.45 (4), p.777-780

2004

Volltextzugriff (PDF)

Autologous stem cell transplantation in multiple myeloma patients <60 vs ≥60 years of age

Bone marrow transplantation (Basingstoke), 2003-12, Vol.32 (12), p.1135-1143

2003

Volltextzugriff (PDF)

Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study

Clinical cancer research, 1996-06, Vol.2 (6), p.947-952

1996

Volltextzugriff (PDF)

Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

Leukemia, 2018-10, Vol.32 (10), p.2305-2305

2018

Volltextzugriff (PDF)

Outcome of unrelated transplants in patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2005-04, Vol.35 (7), p.675-681

2005

Volltextzugriff (PDF)

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony‐stimulating factor alone

British journal of haematology, 2001-01, Vol.112 (1), p.242-247

2001

Volltextzugriff (PDF)

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1513-1518

2015

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(217)

Publikationsform

Artikel
(234)
Berichte
(3)

Sprache

Englisch
(237)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(129)
Science & Technology
(129)
Humans
(123)
Hematology
(85)
Middle Aged
(74)
Oncology
(68)
Biological And Medical Sciences
(64)
Female
(62)
Male
(62)
Medical Sciences
(62)
Adult
(59)
Aged
(50)
Transplantation
(47)
Multiple Myeloma - Therapy
(46)
Multiple Myeloma
(41)
Immunology
(38)
Treatment Outcome
(36)
Hematopoietic Stem Cell Transplantation
(34)
Transplantation, Autologous
(34)
Stem Cell Transplantation
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study

Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation

Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial

Allogeneic stem cell transplantation for multiple myeloma: is there a future?

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I II trial

Graft-Versus-Myeloma Effect: Proof of Principle

Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study

Poor Prognosis in Multiple Myeloma Is Associated Only With Partial or Complete Deletions of Chromosome 13 or Abnormalities Involving 11q and Not With Other Karyotype Abnormalities

Cure of multiple myeloma - more hype, less reality

Autotransplants in Multiple Myeloma: What Have We Learned?

Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF)

Successful Treatment of Systemic and Central Nervous System Lymphomatoid Granulomatosis with Rituximab

Autologous stem cell transplantation in multiple myeloma patients <60 vs ≥60 years of age

Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study

Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

Outcome of unrelated transplants in patients with multiple myeloma

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony‐stimulating factor alone

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

Suchergebnisse filtern